Duocarmycin A
Alternative Names: DUMALatest Information Update: 13 Oct 2006
At a glance
- Originator Kyowa Hakko
- Class Cytostatic antibiotics; Indoles; Pyrrolidinones; Small molecules
- Mechanism of Action DNA inhibitors; DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 13 Oct 2006 Discontinued - Preclinical for Cancer in Japan (unspecified route)
- 08 Apr 2003 No development reported - Preclinical for Cancer in Japan (unspecified route)
- 20 Jul 2001 This compound is still in active development